ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Joshua Sharlin, Ph.D., Launches New Webpage Showcasing FDA Regulatory Expert Witness Services for Pharmaceutical, Biologic, and Medical Device Litigation

Joshua Sharlin, Ph.D., founder of Sharlin Consulting, launches a dedicated webpage offering FDA regulatory consulting and expert witness services in pharmaceutical and medical device cases, covering death or injury, patent infringement, insurance claims, contracts, and criminal matters.

-- Attorneys handling complex litigation involving FDA-regulated products can now access specialized regulatory expertise through the newly launched webpage of Joshua Sharlin, Ph.D., founder of Sharlin Consulting, LLC. The site highlights Dr. Sharlin’s availability as an FDA regulatory expert witness and consultant in legal matters involving pharmaceuticals, biologics, and medical devices.

Dr. Sharlin’s most differentiating skill and experience is his hands-on work on the entire lifecycle of FDA-regulated product development going far beyond just FDA regulatory expertise. This hands-on experience includes, developing regulatory strategy, writing study protocols, identifying and executing the most appropriate statistical analysis, writing code to perform data management and table generation, writing-up study results, auditing sites and vendors for compliance, presenting information to FDA and answering FDA ‘s questions, and his experience as an FDA reviewer, evaluating submissions for safety and efficacy.

What sets Dr. Sharlin apart as an expert witness is his direct, hands-on involvement in every phase of FDA-regulated product development—well beyond just regulatory knowledge. His experience spans designing regulatory strategies, authoring clinical protocols, selecting and implementing appropriate statistical methods, writing custom code for data management and table generation, and drafting clinical study reports. He has conducted compliance audits and solved compliance problems for study sites and vendors, presented complex data to FDA review teams, and directly responded to FDA inquiries. As a former FDA reviewer himself, he brings insider insight into how the agency evaluates safety, efficacy, and compliance in product submissions.

With more than 25 years of FDA compliance experience and a decade of expert witness engagements, Dr. Sharlin supports counsel in high-stakes cases involving:

  • Wrongful death or serious injury
  • Patent and trade secret litigation
  • Insurance disputes tied to FDA labeling or compliance
  • Contract and M&A disputes involving regulatory obligations
  • Stock fraud and SEC matters involving FDA-regulated disclosures
  • Off-label promotion, data integrity violations, and criminal charges

As a former FDA drug reviewer, Ph.D.-level biologist, and seasoned industry consultant, Dr. Sharlin delivers clear, courtroom-ready analyses of FDA submissions, compliance histories, labeling issues, clinical data, software integrity, and adverse event reporting (e.g., MAUDE, FAERS). He has served in more than 50 litigation matters, providing written reports, deposition testimony, and trial appearances.

Dr. Sharlin is also a recognized author and instructor, having developed and taught over 40 FDA compliance and regulatory strategy courses to professional audiences. His ability to translate complex technical and regulatory issues into clear, persuasive language has made him a valuable asset to legal teams across the country.

The new webpage provides:

  • A summary of expert services
  • Access to Dr. Sharlin’s CV
  • A sample case history list
  • Contact information for attorney inquiries

Attorneys seeking independent, scientifically grounded expert opinions on FDA regulatory issues are encouraged to visit the webpage to learn more about how Dr. Sharlin can support litigation strategy and strengthen regulatory arguments.

Contact Info:
Name: Joshua Sharlin, Ph.D.
Email: Send Email
Organization: Sharlin Consulting, LLC.
Phone: (410) 231-8900
Website: https://sharlinconsulting.com/

Release ID: 89166053

In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.